companydata.dkPharmaforce ApS: Financial statements 2022
CVR: 26394198
Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,639,952 and a net result of DKK 282,708 compared with DKK 367,489 the year before. That is a decrease of 13.4% compared with the year before. Equity amounted to DKK 2,858,079. The solvency ratio was 50.7%. The company had 5 employees in the financial year.
- Gross Profit
- 3,639,952 kr.
- Profit/Loss
- 282,708 kr.
- Equity
- 2,858,079 kr.
- Total Assets
- 5,634,632 kr.
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.6 mio. | 283 t. | 2.9 mio. | 5 |
| 2021 | - | 4.2 mio. | 367 t. | 2.9 mio. | 5 |
| 2020 | - | 4.3 mio. | 1.1 mio. | 2.5 mio. | 5 |
| 2019 | - | 2.8 mio. | 264 t. | 1.4 mio. | 4 |
| 2018 | - | 3.7 mio. | 1.2 mio. | 2.2 mio. | 3 |
Keep an eye on Pharmaforce ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharmaforce ApS has published its annual report for 2021. Gross profit came to DKK 4,201,683, and the net result was DKK 367,489.
About Pharmaforce ApS
Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity amounted to DKK 4,328,882.